FactorPad
Build a Better Process

Stock Risk Measures for Taro Pharmaceutical Indus

A quantitative factor review, as of July 31, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: August 02, 2020
See how we arrive at an overall risk score of 71 for TARO below.

/ factorpad.com / stocks / f36dcp.html



TARO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Taro Pharmaceutical Indus. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how TARO stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Pharmaceuticals: Generic industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f36dcp.html


TARO stock risk
TARO PHARMACEUTICAL INDUS stock beta
TARO risk report
TARO f36dcp
TARO risk analysis
TARO volatility
TARO PHARMACEUTICAL INDUS credit risk
TARO liquidity risk
TARO leverage
TARO valuation
TARO systematic risk
TARO specific risk
TARO PHARMACEUTICAL INDUS volatility
TARO analysis
TARO financial ratio